Welcome to our dedicated page for Intuitive Surgical SEC filings (Ticker: ISRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Intuitive Surgical, Inc. (ISRG) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer headquartered in Sunnyvale, California, Intuitive uses these filings to report financial results, material events, and other information relevant to shareholders and regulators.
Among the key documents available are current reports on Form 8-K. Recent 8-K filings include items reporting quarterly financial results under Item 2.02, where Intuitive furnishes press releases detailing revenue, procedure growth on its da Vinci surgical systems and Ion endoluminal system, and changes in the installed base of systems. Another 8-K filing reports a change in the role of a senior executive under Item 5.02, illustrating how the company discloses updates related to its leadership structure.
Investors also use Intuitive’s SEC filings to follow information that may appear in annual reports on Form 10-K and quarterly reports on Form 10-Q, such as risk factor discussions, descriptions of the company’s business and technologies, and summaries of regulatory and market conditions affecting robotic-assisted surgery and minimally invasive care. While these specific forms are not reproduced in the provided excerpts, they are part of the broader filing set accessible through the SEC’s EDGAR system.
On Stock Titan, ISRG filings are paired with AI-powered summaries designed to explain the content and context of complex documents. These tools can help readers understand the significance of earnings releases, regulatory updates, or governance changes without reading every line of each filing. Users can also review filings that relate to financial reporting, such as exhibits containing press releases, and monitor how Intuitive communicates procedure trends, system placements, and other operational metrics to the market.
For investors researching Intuitive’s regulatory history, this page serves as a focused entry point to the company’s SEC disclosures, including 8-Ks that reference earnings announcements and other material developments.
Intuitive Surgical Inc. reported that a senior officer sold company stock. On 12/15/2025, the SVP & Chief Mfg and Supply Chain Officer sold 464 shares of common stock at a price of $548.49 per share in an open market transaction. After this sale, the officer beneficially owned 131 shares, held directly.
The company notes that the trade was executed under a pre-established Rule 10b5-1 trading plan, which is designed to allow insiders to sell shares according to a predetermined schedule. This plan is stated to comply with SEC Rule 10b5-1 and is scheduled to expire on February 14, 2027.
Intuitive Surgical executive Mark Brosius reported an amended insider transaction showing an open-market sale of 312 shares of Common Stock at $547.36 per share on December 12, 2025. After this sale, he directly owned 595 shares.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that is scheduled to expire on February 14, 2027. This Form 4/A corrects the third transaction line from his Form 4 filed on December 15, 2025, which had incorrectly reported that transaction’s details, while all other information in the original filing remained accurate.
Intuitive Surgical executive Mark Brosius reported stock option exercises and share sales. As SVP & Chief Manufacturing and Supply Chain, he exercised 4,500 non-qualified stock options for common stock at an exercise price of $79.6378 per share on 12/12/2025, then sold 4,500 common shares that day at $547.36 per share.
He also sold 464 common shares on 12/15/2025 at $548.49 per share. After these transactions, he directly owned 443 shares of Intuitive Surgical common stock and held no remaining derivative securities from the reported option grant. The filing notes that the transactions were made under a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.
Intuitive Surgical (ISRG) executive Henry L. Charlton reported option exercises and open‑market sales on 11/12/2025 under a Rule 10b5‑1 trading plan. He exercised options for 636, 2,565, 2,898, and 2,901 shares at exercise prices of $347.4167, $245.6, $242.3367, and $177.9867, respectively, and reported multiple sales at $580 per share. Following the transactions, he directly owns 3,056 shares. The plan is stated to expire on June 1, 2026.
Intuitive Surgical (ISRG): Form 4 insider transaction. Director Craig H. Barratt exercised 750 stock options at $71.3233 and sold 750 common shares at $580 on 11/12/2025 under a Rule 10b5-1 trading plan.
Following these transactions, directly held common stock was 0. An additional 27,198 shares were reported as indirectly owned by a trust. The reported option was a non-qualified stock option; the derivative position shown was 0 after the exercise.
Intuitive Surgical (ISRG): Director transaction reported. Director Keith Leonard filed a Form 4 for a gift of 1,606 shares of common stock on 11/12/2025 (transaction code G) at a stated price of $0.0. The filing notes the shares were gifted to a CRUT.
Following the transaction, the reporting person’s beneficial ownership stands at 739 shares, held directly. This is a personal, non-cash transfer and does not reflect a sale in the market.
Intuitive Surgical (ISRG) executive transaction: EVP & Chief Medical Officer Myriam Curet exercised 105 stock options at $229.39 and, on the same day (11/10/2025), sold 105 common shares at $560 under a Rule 10b5-1 trading plan.
Following these transactions, she reported 0 shares held directly, 353 shares held indirectly by a trust, and 1,571 non-qualified stock options remaining outstanding (expiration 02/27/2030).
Intuitive Surgical (ISRG) reported insider activity by EVP & Chief Digital Officer Brian Miller. On 11/10/2025, he exercised options for 1,298 shares at $229.39 and 2,202 shares at $208.90, then sold the same 3,500 shares at $575.00 per share under a Rule 10b5-1 trading plan that expires on December 10, 2025. Following these transactions, he directly owned 5,758 common shares. Remaining derivative holdings included 2,115 and 6,602 non-qualified stock options from prior grants, subject to stated vesting schedules.
Intuitive Surgical (ISRG) reported an insider transaction by its VP Corporate Controller. On 11/05/2025, the officer exercised non-qualified stock options for 1,908 shares at $76.9989 and 159 shares at $59.4622, then sold the same amounts at $550 per share pursuant to a Rule 10b5-1 trading plan. Following these transactions, direct beneficial ownership stood at 473 common shares. The options exercised were granted under the 2010 Incentive Award Plan, with vesting schedules as disclosed.
Intuitive Surgical (ISRG) CEO and Director David J. Rosa reported an insider gift of 5,454 shares of common stock on 11/03/2025, coded G for gift at $0.0 per share. Following the transaction, he directly holds 228,802 shares. The filing notes the shares were gifted to The Rosa Donor Advised Fund.